Wayne M Butler Selected Research

Brachytherapy

11/2021	Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement.
6/2019	Erratum: AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137 [Med. Phys. 36, 5310-5322, 2009].
10/2017	Does supplemental external beam radiation therapy impact urinary, bowel, and erectile function following permanent prostate brachytherapy?: results of two prospective randomized trials.
8/2017	Prostate cancer-specific death in brachytherapy treated high-risk patients stratified by pre-treatment PSA.
3/2016	Focal prostate brachytherapy with (103)Pd seeds.
12/2015	Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts.
9/2015	Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials.
10/2014	Metformin is not associated with improved biochemical free survival or cause-specific survival in men with prostate cancer treated with permanent interstitial brachytherapy.
12/2013	Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment.
9/2013	Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wayne M Butler Research Topics

Disease

87	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 01/2002
28	Neoplasms (Cancer) 03/2016 - 01/2002
13	Hypertension (High Blood Pressure) 11/2009 - 03/2002
8	Erectile Dysfunction 01/2012 - 03/2002
8	Adenocarcinoma 01/2005 - 02/2002
5	Urethral Stricture 10/2017 - 02/2002
5	Neoplasm Metastasis (Metastasis) 12/2013 - 10/2008
4	Diabetes Mellitus 12/2012 - 03/2002
4	Dysuria 10/2007 - 03/2003
3	Obesity 07/2011 - 07/2002
3	Urinary Bladder Neck Obstruction (Bladder Neck Obstruction) 01/2006 - 08/2004
2	Hemorrhage 10/2017 - 01/2004
2	Prostatic Intraepithelial Neoplasia 08/2017 - 08/2013
2	Colorectal Neoplasms (Colorectal Cancer) 09/2012 - 09/2006
2	Pathologic Constriction (Stenosis) 04/2006 - 02/2002
2	Carcinoma (Carcinomatosis) 05/2003 - 03/2002
1	Ulcerative Colitis 11/2020
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2010
1	Overactive Urinary Bladder (Overactive Bladder) 03/2008
1	Rectal Neoplasms (Rectal Cancer) 09/2006
1	Polyps 09/2006
1	Epididymitis 02/2004
1	Proctitis 01/2004
1	Constipation 01/2004
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2003
1	Hypertrophy 01/2003

Drug/Important Bio-Agent (IBA)

19	AndrogensIBA 09/2013 - 01/2004
18	Prostate-Specific Antigen (Semenogelase)IBA 02/2020 - 01/2002
15	IsotopesIBA 03/2007 - 02/2002
14	Hormones (Hormone)IBA 01/2009 - 01/2002
4	Testosterone (Sustanon)FDA Link 01/2018 - 07/2009
4	Sildenafil Citrate (Viagra)FDA Link 05/2003 - 03/2002
3	Palladium-103IBA 09/2015 - 10/2002
2	Dihydrotachysterol (AT 10)IBA 01/2021 - 01/2018
2	Metformin (Glucophage)FDA LinkGeneric 08/2017 - 10/2014
2	Atorvastatin (Lipitor)FDA Link 08/2006 - 12/2005
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2006 - 12/2005
2	Iodine-125IBA 01/2005 - 10/2002
1	Indicators and Reagents (Reagents)IBA 05/2012
1	thiaclopridIBA 06/2010
1	trypsin carboxypeptidase peptide inhibitorIBA 03/2009
1	Agent OrangeIBA 01/2009
1	trospium chloride (Ceris)FDA LinkGeneric 03/2008
1	Dutasteride (Avodart)FDA Link 07/2006
1	bicalutamide (Casodex)FDA LinkGeneric 07/2006
1	prostatic acid phosphataseIBA 05/2005
1	Tamsulosin (Flomax)FDA LinkGeneric 03/2005
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2004

Therapy/Procedure

90	Brachytherapy 11/2021 - 01/2002
26	Radiotherapy 08/2017 - 02/2002
22	Therapeutics 12/2013 - 01/2004
5	Catheters 10/2017 - 07/2002
3	Transurethral Resection of Prostate (TURP) 10/2017 - 01/2004
3	Prostatectomy (Retropubic Prostatectomy) 02/2012 - 08/2008
2	Aftercare (After-Treatment) 12/2013 - 09/2006
1	Colectomy 11/2020
1	Colostomy 09/2012
1	Neoadjuvant Therapy 08/2008
1	Urinary Catheters 10/2007